Skip to content
S2Medical

Technology · Skin grafting

Instagraft skin grafting device

Instagraft® is our own skin grafting technology, developed in the subsidiary Instagraft AB. It closes the wound after debridement and infection control, with a minimally invasive technique for re-epithelialisation. It builds on what we learned from EPIPROTECT®, the biosynthetic cellulose dressing S2Medical developed and which is today owned and carried forward by ABENA.

Instagraft®

Technology
Minimally invasive skin grafting
Role
Re-epithelialisation
Developed by
Instagraft AB (S2Medical group)
Heritage
Biosynthetic cellulose dressing

The graft question

Skin grafting without donor sites

Conventional grafting often creates a second wound at the donor site. Instagraft is built to close the wound without that step: a minimally invasive route to re-epithelialisation.

Conventional grafting

  • Requires a donor site
  • Creates a second wound
  • Supply and handling constraints

Instagraft®: ours

  • Minimally invasive grafting technique
  • Developed in the subsidiary Instagraft AB
  • Built on our biosynthetic dressing heritage

Evidence · Instagraft®

Scientific evidence in preparation

Verified studies and source-linked results for Instagraft will be added here.

Reserved for verified evidence

STUDY · RESULT · SOURCE